HER-2 substrate peptide GGMEDIYFEFMGGKKK-amide

Description

Substrate for ErbB-2/HER-2 receptor tyrosine kinase

See full description

Catalogue number crb1000259
Sequence (one letter code) GGMEDIYFEFMGGKKK-amide
Sequence (three letter code) H-Gly-Gly-Met-Glu-Asp-Ile-Tyr-Phe-Glu-Phe-Met-Gly-Gly-Lys-Lys-Lys-NH2
Aliases HER2 substrate
Research Area Cancer
Purity >95%
Molecular Weight 1836.14
References

Muniyan et al (2015) ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells. Cell Signal, 27(11) 2261 PMID: 26257301

Qiu et al (2008). Mechanism of Activation and Inhibition of the HER4/ErbB4 Kinase. Structure, 16(3) 460 PMID: 18334220

Collier et al (2013) Carboxyl Group Footprinting Mass Spectrometry and Molecular Dynamics Identify Key Interactions in the HER2-HER3 Receptor Tyrosine Kinase Interface. J. Biol. Chem. 288(35) 25254 PMID: 23843458

Human epidermal growth factor receptor 2 (HER-2)/epidermal growth factor receptor-2 (ErbB-2), is a key receptor linked to metastasis in tumours. The oncogenic ErbB-2 receptor has intrinsic receptor tyrosine kinase (RTK) activity. The receptor is activated by ligand binding which induces receptor dimerization. These RTK complexes can activate mitogen-activated protein kinase (MAPK) and phosphoinositol 3′-kinase (PI3K)/Akt pathways. This peptide has been identified as a substrate for HER-2/ErbB-2 as it is phosphorylated upon receptor activation and therefore acts as a marker for receptor activation in kinases assays.

HER-2 substrate peptide

Cat No. Pack Size Price Qty

crb1000259h

0.5mg

$112.50

crb1000259j

1mg

$150.00